Articles On Apiam Animal Health (ASX:AHX)

The ASX 200 Health Index (XHJ) is up by 1.5% at the time of writing, compared to the broader index which is up by 0.40%. Mesoblast (ASX:MSB) jumped 10% after reporting data from its Phase 3 trial of rexlemestrocel-L in chronic heart failure...

Highlights ESG investing is known to be a kind of investing that considers a company’s financial returns along with its impact on environment, stakeholders, and planet. ESG stands for Environmental, Social, and Governance. Investors...

Australia’s largest regional veterinary network records a strong start to the 2022 financial year with revenue and profit growth up, along with completing key acquisitions. Strong revenue growth in its dairy and mixed animal clinics have u...

A thorough understanding of the operations of a rural veterinary clinic, along with communities Apiam serves, has proven to be a successful formula. The veterinary needs of local communities has been credited as a key factor in the success...

Australia’s largest regional vet network Apiam Animal Health is determined to do its part in putting an end to the mental health and suicide crisis gripping the sector.  As it continues to build its market dominance in Australia’s rural an...

In a ground-breaking study, commissioned by the Meat & Livestock Association (MLA), farmers and meat processors have validated the use of ‘Assisted Reality’ wearable technology. Findings are already being commercially-implemented by lea...

Summary  ASX-listed animal health business Apiam disclosed the acquisition of Golden Plains Group to expand its market presence. Anatara Lifesciences completed a challening experiment in weaner piglets with its BONIFF (bromelain-based...

Golden Plains Group is comprised of two high-performance veterinary clinics being Golden Plains Animal Hospital in Bannockburn and Smythesdale Animal Hospital near Ballarat.

The company has the resources and market footprint to attract the best vets as it builds out a dominant market footprint in Australia’s animal health sector. Investors in animal health company Apiam (ASX:AHX) have reaped the benefits of its...

The company is snapping up earnings-accretive deals as it takes advantage of a generational market opportunity in regional growth corridors. Investors tracking the progress of veterinary and animal health company Apiam (ASX:AHX) would know...

MoneyTalks is Stockhead’s regular recap of the ASX stocks, sectors and trends that fund managers and analysts are looking at right now and in this edition we’re looking at potential takeover targets. Today we hear from Luke Laretive from Se...

If I were given $2,000 to invest into ASX shares, I know the two stocks I’d want to pick. I believe that businesses that are smaller have more growth potential. In my opinion, the following two options are good ideas: WAM Microcap Limited...

Wall Street takes record highs even higher All three US benchmarks rose overnight, as American consumer confidence for April rose the highest since the pandemic began and US house prices jumping the most in three decades. The Dow Jones and...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Apiam’s two brand new clinics in regional Victoria are already delivering on early growth expectations. The strength of Apiam’s (ASX:AHX) regional expansion strategy for its vet clinics and animal health practices hasn’t been lost on invest...

By Tim Boreham, Editor, The New Criterion Where to find pet care stocks amid a paw-city of choice Even before the pandemic spurred the panic puppy purchasing phenomenon, Australian pet ownership was on the rise because of the powerful demog...

Even before the pandemic spurred the panic puppy purchasing phenomenon, Australian pet ownership was on the rise because of the powerful demographic trend to single occupant households. With pooches and moggies and other random beasts displ...

Summary The ASX was trading flat at 7,095 with marginal gains by afternoon, tracking a muted session on Wall Street. Costa Group Holdings was the top percentage loser of the ASX, falling nearly 23% to AU$3.43. Seven of 11 sectors were...

Wall Street inches higher All major US indices rose overnight. The Dow Jones index finished higher by 0.03%, S&P by 0.19%, and tech heavy NASDAQ by 0.59%. Ford rose by 8.5%, after saying that it expects 40 per cent of its sales to come...

CEO Dr Chris Richards said the new ruling will allow Apiam to bring in experienced vets to high-growth areas where it needs them most. The Morrison government has been front and centre this week after handing down the Federal Budget on Tues...

The company has consolidated its first-mover advantage in Australia’s booming regional growth corridors. Apiam (ASX:AHX) is set to deliver further growth in the June quarter as its regional expansion strategy gathers pace. In the wake of a...

The capital raisings boom on the ASX is continuing in 2021 with nearly $10 billion raised in the first four months of the year. Across 325 deals, ASX companies have raised $9.878 billion in capital amidst IPOs, placements and rights issues....

Among post-COVID trends, one for Aussie investors to be aware of is a notable demographic shift to regional centres. With travel curtailed amid the broader disruption caused by the pandemic, residents of Australia’s larger cities have incre...

Shaw and Partners was pleased to be appointed as Lead Manager to the capital raising by Apiam Animal Health.   The company successfully completed an Institutional Placeme... Read More

Apiam CEO Dr Chris Richards said the company now has a chance to capitalise on an “exciting market opportunity”. Animal health company Apiam (ASX:AHX) is executing on a major regional expansion strategy, and the company’s institutional shar...

Listed veterinary products and services outfit Apiam Animal Health has restocked its acquisition kitty. 

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Source: Pressmaster, Shutterstock Summary The pet care industry has flourished during the pandemic, with pet care stocks benefitting from the unprecedented scenario. During 1H FY21, Apiam delivered resilient revenue growth driven by s...

Investors are now backing Apiam to pursue a targeted growth-by-acquisition strategy as it scales up across regional Australia. For animal healthcare company Apiam (ASX:AHX), 2021 has gotten off to a cracking start as the company builds out...

If you want to know which ASX stocks fund managers and famous investors are putting their money into we’ve been keeping track of substantial holder buys (and sells). Trading Places is Stockhead’s recap of the substantial holder movements am...

Australia has one of the highest rates of household pet ownership in the world. The RSPCA estimates 61 per cent of Australian households own pets and all up there are over 29 million pets across the country. The most common domesticated an...

The Apiam Animal Health Ltd (ASX: AHX) share price is soaring today following the release of a positive Q1 update. The animal health company’s shares broke its share price record today, up 12% at a high of 70 cents at close of trade. The r...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Au...

Small caps Shaver Shop (ASX:SSG) and Apiam Animal Health (ASX:AHX)  reported strong profits for FY20 despite COVID-19. Shaver Shop’s profit after tax was $10.6 million – up 45 per cent from the prior corresponding period. This was from sale...

StockTalk is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Dr Nigel Finch discusses the ‘hidden gem’ animal health market. Populating the expert panel this week...

Nearly two years of pain for Factor Therapeutics (ASX:FTT) shareholders could be over soon with the company signing a term sheet to negotiate a potential acquisition. In 2018, Factor was trying to commercialise a wound-dressing drug, which...

While hand sanitiser demand took off thanks to COVID-19, there are also new markets emerging for products to protect animals. One small cap started with the pig industry, but is now eyeing the potentially lucrative horse racing industry. La...

In looking for opportunities in a heavily sold off market, Finfeed yesterday ran the ruler across five speculative stocks that were in sectors traditionally not for the risk averse. However, as we outlined, these companies have been support...

The property market looks to be heading north again after an 18-month slump, and McGrath’s (ASX:MEA) half-yearly results are reflecting the turnaround. After the property market slumped following a housing bubble between 2017 and 2018, the...

Zoono Group (ZNO) has released its quarterly report for the December quarter — which saw an almost-500 per cent bump in shares The strong quarter came off the back of the Zoono Z71 product which piqued the interest of a Chinese distributo...

New Zealand’s medicines regulator has recommended the country fall in line with Australia’s new codeine restrictions, and pharmaceutical companies are backing the decision. Yesterday, Medsafe recommended that all medications containing code...

Who needs human companionship when we have pets? They’re loyal, always happy to see you and won’t divorce you and take half your stuff. According to the RSPCA, Australia is home to 24 million domestic animals. Dogs were present in 38 per ce...

Australia’s S&P/ASX 200 (Index: ^AXJO)(ASX: XJO) and ALL ORDINARIES (Index: ^AXAO) (ASX: XAO) indices finished higher on Thursday. Here’s a short recap of the Australian market: S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) higher 0.23%...

For a certain generation of investors the word ‘laser’ is indelibly tied to a Dr Evil reference. Over the last two years Invion (ASX:IVX) has been valiantly working against this association, and today says its lasers (not attached to the he...

An ex-football chairman and the CFO of an animal feed company walked into a bar the stock market and bought $100,000 worth of shares each in a pot stock. That might sound like a joke itself but last week it actually happened. Althea Group (...

Nearly 11 months on from its failed clinical trial and subsequent 97 per cent share price crash; Factor Therapeutics (ASX: FTT) has $3.1 million cash and a pipeline of opportunities but is yet to decide on one. Factor chairman Cherrell Hirs...

An additional news report on the recommendation, valuation, forecast and opinion changes for ASX-listed equities. In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The...

DroneShield (ASX:DRO) shares climbed as much as 12 per cent higher this morning after the company reported it made about $1.1m from selling drones. This is the third quarter in a row that DroneShield has increased its sales revenue. With go...

Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. The market opens at 10am (eastern time) and the data is taken as at 10:15am, once every stock has commenced trading. Stocks highlighted in...